ATE316530T1 - Verfahren zur herstellung von 2-(7-chloro-1,8- - Google Patents

Verfahren zur herstellung von 2-(7-chloro-1,8-

Info

Publication number
ATE316530T1
ATE316530T1 AT03708410T AT03708410T ATE316530T1 AT E316530 T1 ATE316530 T1 AT E316530T1 AT 03708410 T AT03708410 T AT 03708410T AT 03708410 T AT03708410 T AT 03708410T AT E316530 T1 ATE316530 T1 AT E316530T1
Authority
AT
Austria
Prior art keywords
chloro
producing
Prior art date
Application number
AT03708410T
Other languages
English (en)
Inventor
T L Stuk
S M Jennings
Original Assignee
Indevus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indevus Pharmaceuticals Inc filed Critical Indevus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE316530T1 publication Critical patent/ATE316530T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03708410T 2002-03-29 2003-03-17 Verfahren zur herstellung von 2-(7-chloro-1,8- ATE316530T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36860902P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
ATE316530T1 true ATE316530T1 (de) 2006-02-15

Family

ID=28675512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03708410T ATE316530T1 (de) 2002-03-29 2003-03-17 Verfahren zur herstellung von 2-(7-chloro-1,8-

Country Status (17)

Country Link
US (3) US6949653B2 (de)
EP (1) EP1490363B1 (de)
JP (1) JP4471664B2 (de)
AR (1) AR039169A1 (de)
AT (1) ATE316530T1 (de)
AU (1) AU2003212585B2 (de)
CA (1) CA2480776C (de)
CY (1) CY1105785T1 (de)
DE (1) DE60303363T2 (de)
DK (1) DK1490363T3 (de)
ES (1) ES2256723T3 (de)
IL (2) IL164377A0 (de)
NZ (1) NZ535685A (de)
PT (1) PT1490363E (de)
RU (1) RU2318823C2 (de)
TW (1) TWI237639B (de)
WO (1) WO2003082870A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1490363T3 (da) * 2002-03-29 2006-05-15 Indevus Pharmaceuticals Inc Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon
CN109988164B (zh) * 2017-12-31 2021-12-07 中国医学科学院药物研究所 盐酸小檗碱与苹果酸共晶物及制备方法和其组合物与用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208414A1 (es) 1974-11-07 1976-12-27 Rhone Poulenc Ind Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
FR2607503B1 (fr) 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
US5532228A (en) * 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
FR2678934B1 (fr) 1991-07-12 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de l'isomere dextrogyre d'un derive de l'isoindolinone.
FR2678932B1 (fr) 1991-07-12 1993-09-24 Rhone Poulenc Rorer Sa Procede de preparation des isomeres optiques d'un derive de l'amino-2 naphtyridine.
FR2678933B1 (fr) 1991-07-12 1993-09-24 Rhone Poulenc Rorer Sa Procede de preparation des isomeres optiques d'un derive de l'amino-2 naphtyridine.
FR2681068B1 (fr) 1991-09-09 1993-11-19 Rhone Poulenc Rorer Sa Procede de preparation de l'isomere dextrogyre d'un derive de l'isoindolinone.
FR2684673B1 (fr) 1991-12-04 1994-01-21 Rhone Poulenc Rorer Sa Procede de preparation d'un derive de l'amino-2 naphtyridine racemique.
FR2685330B1 (fr) 1991-12-20 1994-02-04 Rhone Poulenc Rorer Sa Procede de preparation des enantiomeres d'un derive de l'isoindolinone.
FR2687154B1 (fr) 1992-02-07 1995-05-12 Rhone Poulenc Rorer Sa Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
FR2695389B1 (fr) 1992-09-08 1994-11-04 Rhone Poulenc Rorer Sa Nouveau dérivé de l'isoindolinone, sa préparation et les compositions pharmaceutiques qui le contiennent.
US5498716A (en) 1994-01-12 1996-03-12 Rhone-Poulenc Rorer S.A. 2-amino naphthyridine derivative, its preparation and its use
DK1490363T3 (da) * 2002-03-29 2006-05-15 Indevus Pharmaceuticals Inc Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon

Also Published As

Publication number Publication date
IL164377A (en) 2011-07-31
EP1490363A1 (de) 2004-12-29
WO2003082870A1 (en) 2003-10-09
DE60303363T2 (de) 2006-10-12
US20060194830A1 (en) 2006-08-31
TW200305406A (en) 2003-11-01
US7304158B2 (en) 2007-12-04
AU2003212585B2 (en) 2009-02-26
CA2480776C (en) 2010-11-23
JP4471664B2 (ja) 2010-06-02
US20030191315A1 (en) 2003-10-09
US6949653B2 (en) 2005-09-27
RU2004131835A (ru) 2005-07-10
EP1490363B1 (de) 2006-01-25
AR039169A1 (es) 2005-02-09
DK1490363T3 (da) 2006-05-15
IL164377A0 (en) 2005-12-18
AU2003212585A1 (en) 2003-10-13
DE60303363D1 (de) 2006-04-13
RU2318823C2 (ru) 2008-03-10
NZ535685A (en) 2007-04-27
ES2256723T3 (es) 2006-07-16
CY1105785T1 (el) 2011-02-02
PT1490363E (pt) 2006-06-30
TWI237639B (en) 2005-08-11
US7057047B2 (en) 2006-06-06
CA2480776A1 (en) 2003-10-09
US20050288322A1 (en) 2005-12-29
JP2005528369A (ja) 2005-09-22

Similar Documents

Publication Publication Date Title
DE60325188D1 (de) Verfahren zur herstellung von sterilen, stabilisierten nanodispersionen
ATE340819T1 (de) Verfahren zur herstellung von polyamiden
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE353322T1 (de) Verfahren zur herstellung von 2- (chinoxalin-5- ylsulfonylamino) -benzamid-verbindungen
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
ATE515500T1 (de) Verfahren zur herstellung von telmisartan
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
ATE448209T1 (de) Verfahren zur herstellung von pyrimidinverbindungen
DE602004022134D1 (de) Verfahren zur herstellung von dinitrilen
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE336478T1 (de) Verfahren zur herstellung von benzophenonen
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE323677T1 (de) Verfahren zur herstellung von 4-amino-2,5- bisheterocyclylchinazolinen
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
ATE349442T1 (de) Verbessertes verfahren zur herstellung von alpha- polymorphem eletriptan hydrobromid
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
DE60336173D1 (de) Verfahren zur herstellung von vanadylpyrophosphat-katalysatoren
ATE371642T1 (de) Verfahren zur herstellung von 3- methylthiopropanal
ATE352573T1 (de) Verfahren zur herstellung von copolymerisaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1490363

Country of ref document: EP